Pulmonary complications associated with combination chemotherapy programs containing bleomycin
- 1 April 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 74 (4), 557-563
- https://doi.org/10.1016/0002-9343(83)91009-4
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Cytotoxic drug-induced pulmonary disease: Update 1980The American Journal of Medicine, 1980
- Pulmonary histopathologic changes associated with melphalan therapyCancer, 1978
- Pulmonary disease with chlorambucil therapyCancer, 1978
- Cytotoxic drug-induced lung diseaseThe American Journal of Medicine, 1977
- Cyclophosphamide therapy and interstitial pulmonary fibrosisCancer, 1976
- Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancerCancer, 1976
- Large-Dose Bleomycin Therapy and Pulmonary ToxicityPublished by American Medical Association (AMA) ,1976
- A clinical review of bleomycin—a new antineoplastic agentCancer, 1973
- Hypersensitivity to procarbazine (Matulane®) manifested by fever and pleuropulmonary reactionCancer, 1972
- Interstitial pulmonary fibrosis following busulfan therapyThe American Journal of Medicine, 1961